痤疮治疗药物市场规模、份额和增长分析（按产品、类型、给药途径、年龄组、分销渠道和地区）- 2025-2032 年行业预测

痤疮治疗市场预计将在 2023 年达到 111 亿美元，从 2024 年的 120.3 亿美元增长到 2032 年的 229.4 亿美元，预测期内（2025-2032 年）的复合年增长率为 8.4%。

痤疮仍然是全球最常见的皮肤病之一，影响着不同年龄层的数百万人，对有效治疗的需求庞大。人们对皮肤健康、外观和自我护理意识的增强导致人们对痤疮药物的兴趣增加。皮肤病学领域的不断研究和开发带来了创新有效的药物，包括先进的外用、口服和联合治疗。此外，压力、饮食选择和污染等现代生活方式因素与痤疮的关係越来越密切，越来越多的人寻求针对这些皮肤问题的针对性解决方案。随着人们对痤疮及其对生活方式的影响的认识不断提高，痤疮药物市场不断扩大，优先为消费者提供有效、客製化的治疗方案。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管格局
• 案例研究
• 技术进步
• 贸易分析
• 客户和购买标准分析

痤疮治疗市场规模（按产品和复合年增长率） (2025-2032)

• 市场概况
• 外用类视色素
• 口服抗生素
• 口服类视色素
• 场外交易（OTC）
• 异维他命A酸
• 其他的

痤疮治疗药物市场规模（按类型和复合年增长率）（2025-2032）

• 市场概况
• 发炎性痤疮
• 非发炎性痤疮

痤疮治疗市场规模（按给药途径和复合年增长率） (2025-2032)

• 市场概况
• 局部的
• 口服
• 注射

痤疮治疗市场规模（按年龄组别划分）及复合年增长率（2025-2032 年）

• 市场概况
• 10 至 17 岁
• 18 至 44 岁
• 45 至 64 岁
• 年龄 65 岁或以上

痤疮治疗药物市场规模（按分销管道和复合年增长率） (2025-2032)

• 市场概况
• 医院药房
• 零售药局
• 网路药局
• 其他的

痤疮治疗市场规模及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分析市场份额
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Johnson & Johnson Services, Inc.（USA）
• GlaxoSmithKline plc（GSK）（United Kingdom）
• Pfizer Inc.（USA）
• AbbVie Inc.（USA）
• Sun Pharmaceutical Industries Ltd.（India）
• Bausch Health Companies Inc.（Canada）
• Nestle Skin Health SA（Switzerland）
• Bayer AG（Germany）
• Viatris Inc.（USA）
• Teva Pharmaceutical Industries Ltd.（Israel）
• F. Hoffmann-La Roche Ltd（Switzerland）
• LEO Pharma A/S（Denmark）
• Mylan NV（USA）
• Mayne Pharma Group Limited（Australia）
• Zydus Lifesciences Limited（India）
• Crown Laboratories（USA）
• Stryke Club（USA）

结论和建议

Acne Medication Market size was valued at USD 11.1 billion in 2023 and is poised to grow from USD 12.03 billion in 2024 to USD 22.94 billion by 2032, growing at a CAGR of 8.4% during the forecast period (2025-2032).

Acne remains one of the most prevalent skin conditions worldwide, impacting millions across various age groups and driving significant demand for effective treatments. Growing awareness of skin health, appearance, and self-care is fueling interest in acne solutions. Continuous research and development in dermatology have resulted in innovative and effective medications, including advanced topical and oral treatments, as well as combination therapies. Additionally, modern lifestyle factors such as stress, dietary choices, and pollution are increasingly associated with acne, prompting individuals to seek targeted solutions for these skin concerns. As awareness and lifestyle impacts converge, the market for acne medication continues to expand, prioritizing effective and tailored treatment options for consumers.

Top-down and bottom-up approaches were used to estimate and validate the size of the Acne Medication market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Acne Medication Market Segments Analysis

Global Acne Medication Market is segmented by Product, Type, Route of Administration, Age Group, Distribution Channel and region. Based on Product, the market is segmented into Topical Retinoids, Oral Antibiotics, Oral Retinoids, Over-the-Counter (OTC) Drugs, Isotretinoin and Others. Based on Type, the market is segmented into Inflammatory Acne and Non-inflammatory Acne. Based on Route of Administration, the market is segmented into Topical, Oral and Injectable. Based on Age Group, the market is segmented into 10 to 17 Years, 18 to 44 Years, 45 to 64 Years and 65 Years & Above. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Acne Medication Market

The rising need for effective acne treatment options has led to the launch of numerous products tailored to address this issue, such as retinoids, isotretinoins, and both oral and topical antibiotics. These diverse offerings have significantly contributed to increasing global awareness regarding acne treatments and the various products available to manage it. This heightened awareness, in turn, has been instrumental in driving the growth of the acne medication market, as more individuals seek solutions for their skin concerns. As a result, the market is expanding rapidly, catering to the increasing demand for effective acne care solutions.

Restraints in the Acne Medication Market

Although chronic acne is a widespread issue globally, the expansion of the acne medication market faces several challenges. A significant hurdle is the side effects linked to various acne treatment medications. Research by the National Center for Biotechnology Information (NCBI) indicates that around 7% of individuals using tetracycline and 4% of those on macrolides report adverse effects, including nausea, vomiting, and diarrhea. These reactions can deter patients from seeking treatment and adhering to prescribed regimens, ultimately restraining the market's growth potential and limiting the effectiveness of available therapeutic options.

Market Trends of the Acne Medication Market

The global acne medication market is witnessing robust expansion, propelled by a surge in awareness regarding skincare and rising acne prevalence among teenagers and adults alike. Factors such as hormonal fluctuations and lifestyle choices-characterized by increased stress and dietary changes-are contributing to acne incidences. Furthermore, the growing trend of proactive skincare regimes among consumers is driving the adoption of specialized acne treatments, including topical solutions and oral medications. Innovations in formulation, including natural and cruelty-free products, are also aligning with consumer preferences, bolstering market penetration. As a result, the acne medication market is projected to sustain its upward trajectory in the coming years.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Advancement
• Trade Analysis
• Customer & Buying Criteria Analysis

Global Acne Medication Market Size by Product & CAGR (2025-2032)

• Market Overview
• Topical Retinoids
• Oral Antibiotics
• Oral Retinoids
• Over-the-Counter (OTC) Drugs
• Isotretinoin
• Others

Global Acne Medication Market Size by Type & CAGR (2025-2032)

• Market Overview
• Inflammatory Acne
• Non-inflammatory Acne

Global Acne Medication Market Size by Route of Administration & CAGR (2025-2032)

• Market Overview
• Topical
• Oral
• Injectable

Global Acne Medication Market Size by Age Group & CAGR (2025-2032)

• Market Overview
• 10 to 17 Years
• 18 to 44 Years
• 45 to 64 Years
• 65 Years & Above

Global Acne Medication Market Size by Distribution Channel & CAGR (2025-2032)

• Market Overview
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Others

Global Acne Medication Market Size & CAGR (2025-2032)

• North America (Product, Type, Route of Administration, Age Group, Distribution Channel)
  • US
  • Canada
• Europe (Product, Type, Route of Administration, Age Group, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Type, Route of Administration, Age Group, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Type, Route of Administration, Age Group, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Type, Route of Administration, Age Group, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Johnson & Johnson Services, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline plc (GSK) (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AbbVie Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Pharmaceutical Industries Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bausch Health Companies Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nestle Skin Health S.A. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Viatris Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LEO Pharma A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mylan N.V. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mayne Pharma Group Limited (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zydus Lifesciences Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Crown Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryke Club (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations